2008.

1) M.G. Valorani, A. Germani, W.R. Otto, C.P. Khoo, M.I. Hawa, M.R. Alison, P. Pozzilli, M.P. Patrizi .
Effect of hypoxia on mesenchymal stem cell adipogenic differentiation. Sixth Annual meeting of the International Federation of Adipose Therapeutics and Science (IFATS), Toulose, France, October 24-26, 2008

2) M.G. Valorani, A. Germani, W.R. Otto, F. Chaudry, C.P. Khoo, C. Guglielmi, M.I. Hawa, U. Johansson, M.R. Alison, P. Pozzilli . hypoxia increases production of pure mscs from adipose tissue and bone marrow: potential implications for their use for beta cell replacement. William Harvey Day, St. Bartholomew’s Hospital, London., 14 October 2008

3) C. P. Khoo, N. Hill, M.G. Valorani, A. Signore, P. Pozzilli; Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse. 44 EASD Annual Meeting, Rome, Italy 07-11Sept 2008

4) C. Guglielmi, E. Astorri, R. Portuesi, M. Bombardieri, M.G. Valorani, P. Pozzilli; A diet rich in protein and poor in starch with reduced food intake prevents diabetes in the NOD mouse: the significance of Reg gene expression in the pancreas. 44 EASD Annual Meeting, Rome, Italy 07-11 Sept 2008

5) M.G. Valorani, W.R. Otto , A. Germani , F. Chaudry , C.P. Khoo , C. Guglielmi , M.I. Hawa, U. Johansson , M.R. Alison, P. Pozzilli. Hypoxia increases production of pure MSCs from adipose tissue and bone marrow: potential implications for their use for beta cell replacemen. ESH-EHA Scientific Workshop, Mesenchymal Stem Cells , 30 June - 2 July, 2008 - Mandelieu, France

6) Valorani M.G., Otto W.R., Tropel P., Germani A., Khoo C.P., Guglielmi C., Hawa M.I., Johansson U., Alison M.R., Pozzilli P. Hypoxia increases production of pure MSCs from NOD mouse Adipose Tissue and Bone Marrow
Developments in cell culture technology to enhance cell growth in vitro. May 02, 2008. BioPark Hertfordshire Welwyn Garden City, UK.

7) Marta Vadacca, Maria Giuditta Valorani, Robert E Humphreys, Nikoletta Kallinteris, Luciana Valente, Paolo Pozzilli
Ii-Key-Hybrid Technology To Detect T Cell Response To Insulin And GAD In Type 1 Diabetes
68th ADA Congress, June 6-10, 2008 San Francisco, CA. 2008-A-3764-Diabetes